Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Asthma and Allergic Rhinitis
NCT03380975Phase 4Completed
- Sponsor
- Clinision
- Start
- Aug 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in asthma, allergic rhinitis (AR), sponsored by Clinision. Started Aug 2018; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03380975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380975.